CPC A01N 63/40 (2020.01) [A01N 25/10 (2013.01); A01N 63/50 (2020.01)] | 20 Claims |
1. A product effective in mitigating contamination of a surface thereof by particles of an infectious virus to humans for which an enveloped bacterial virus characterized by having a lipid-rich viral membrane envelope is a biological surrogate, wherein the product is made by a process comprising the steps of:
applying an anti-viral functionalized coating composition on a surface of a substrate to create an anti-viral functionalized surface thereof, wherein the anti-viral functionalized coating composition comprises an effective amount of an anti-viral additive and a specified amount of a polymeric coating composition, wherein the anti-viral additive comprises antimicrobial peptide and lipolytic enzyme, wherein said antimicrobial peptide comprises SEQ ID NO. 40, wherein the effective amount of the anti-viral additive and the specified amount of the polymeric coating composition enable the anti-viral functionalized surface to provide the product with an effective amount of contamination mitigation of particles of the biological surrogate contacting the anti-viral functionalized surface, and wherein the anti-contaminant additive comprising said SEQ ID NO. 40 and said lipolytic enzyme provides increased neutralization of activity of the biological surrogate as compared to said neutralization when the anti-contaminant additive comprises only said SEQ ID NO. 40 or said lipolytic enzyme.
|